Testicular germ cell tumors (TGCTs) represent the most common solid tumors among men
aged 15 to 34 years. Fortunately, recent advances have made testicular cancer a highly …

Testicular germ cell tumors (TGCTs) represent the most common solid tumor in young men
and is a model of curable cancer. The effectiveness of cisplatin-based chemotherapy …

Background Covalent RNA modifications, such as N-6-methyladenosine (m 6 A), have been
associated with various biological processes, but their role in cancer remains largely …

Background: Post-chemotherapy retroperitoneal lymph node dissection (PC-RPLND) plays
a crucial role in treatment of metastatic non-seminomatous germ cell cancer. Objective: To …

Germ cell cancers are the most common solid tumors among men between 15 and 40 years.
With a worldwide incidence of 70,000, germ cell cancers account for 1% of the male tumors …

Background This paper describes the testicular cancer trends for incidence, survival, socio-
economic status (SES) disparities and second cancer occurrence in Geneva, Switzerland, a …

Testicular cancer is a relatively uncommon malignancy, and accounts for 1% of all cancers
and 5% of urologic tumors; however, it is the most common solid malignancy in males …

Testicular cancer has excellent cure rates; however, poor guideline adherence can lead to
inappropriate management, with a detrimental effect on outcomes. Therefore, we aimed to …

We here describe the development of an evidence‐based cancer dataset by an International
Collaboration on Cancer Reporting expert panel for the reporting of primary testicular …

Objectives To report the long‐term results of the sentinel node (SN) approach in patients
with clinical stage I testicular tumours in our facility. Patients and Methods We conducted an …